64062 Federal Register / Vol. 69, No. 212 / Wednesday, November 3, 2004 / Notices 

c. New Budget Period Program 

Proposed Activity Objectives. 

d. Budget. 

e. Measures of Effectiveness. 

f. Additional Requested Information. 

2. Financial status report, due no later 

than 90 days after the end of the budget 

period/project. 

These reports must be mailed to the 

Grants Management or Contract 

Specialist listed in the ‘‘Agency 

Contacts’’ section of this announcement. 

VII. Agency Contacts 

We encourage inquiries concerning 

this announcement. For general 

questions, contact: Technical 

Information Management Section, CDC 

Procurement and Grants Office, 2920 

Brandywine Road, Atlanta, GA 30341, 

Telephone: 770–488–2700. 

For program technical assistance, 

contact: Vivian Bryant, Program 

Analyst, CDC National Center for 

Chronic Disease Prevention and Health 

Promotion, 4770 Buford Hwy NE., 

Atlanta, GA 30341–3717, Telephone: 

770–488–6292, E-mail: 

vbryant@cdc.gov.

For financial, grant management, or 

budget assistance, contact: Rick Jaeger, 

Grants Management Specialist, CDC 

Procurement and Grants Office, 2920 

Brandywine Road, Atlanta, GA 30341, 

Telephone: 770–488–2727, E-mail: 

rjaeger@cdc.gov.

VIII. Other Information 

This and other CDC funding 

opportunity announcements can be 

found on the CDC Web site, Internet 

address: http://www.cdc.gov. Click on 

‘‘Funding’’ then ‘‘Grants and 

Cooperative Agreements.’’

Dated: October 28, 2004. 

William P. Nichols, 

Acting Director, Procurement and Grants 

Office, Centers for Disease Control and 

Prevention.

[FR Doc. 04–24513 Filed 11–2–04; 8:45 am] 

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

State Implementation Projects for 

Preventing Secondary Conditions and 

Promoting the Health of People With 

Disabilities 

Announcement Type: New. 

Funding Opportunity Number: RFA 

05007. 

Catalog of Federal Domestic 

Assistance Number: 93.184. 

Key Dates: Letter of Intent Deadline 

(LOI): December 3, 2004. 

Application Deadline: January 3, 

2005. 

Executive Summary: The State 

capacity cooperative agreements are 

providing financial assistance to: (1) 

Establish and/or sustain State offices for 

preventing secondary conditions and 

promoting the health of people with 

disabilities as a State public health 

priority, and serve as a technical 

assistance (TA) resource and statewide 

focus for the prevention of secondary 

conditions; (2) support an advisory 

function to coordinate and provide 

policy and program direction guidance 

in the State; (3) develop and/or 

implement a State strategic plan or 

policy instrument for health promotion 

for persons with disabilities; (4) 

establish and implement partnerships 

with universities or state health 

departments or other state agencies to 

support and complement project 

activities; (5) maintain and refine 

prescribed public health surveillance or 

survey activities related to disability 

and/or secondary conditions in order to 

implement prevention efforts and 

program evaluation activities; (6) 

provide TA to communities; and (7) 

promote education and health 

promotion programs for persons with 

disabilities, conduct training of health 

professionals, and facilitate access to 

services for persons with disabilities. 

I. Funding Opportunity Description

Authority: This program is authorized 

under Sections 311, 317(k)(2), and 317C of 

the Public Health Service Act, (42 U.S.C. 243, 

247b(k)(2), and 247b–4) as amended.

Purpose: The Centers for Disease 

Control and Prevention (CDC) 

announces the availability of fiscal year 

(FY) 2005 funds for cooperative 

agreements for State implementation 

projects for preventing secondary 

conditions and promoting the health of 

persons with disabilities. This program 

addresses the ‘‘Healthy People 2010’’

focus area(s) of Disability and 

Secondary Conditions. 

The purpose of this program is to 

support States in preventing secondary 

conditions in persons with disabilities 

and in implementing effective health 

promotion and wellness programs for 

persons with disabilities. This 

announcement is comprised of two 

levels of cooperative agreements:

Level II—State Implementation Projects 

Level III—State Infrastructure 

Development Projects

Measurable outcomes of the program 

will be in alignment with one (or more) 

of the following performance goal(s) for 

the National Center on Birth Defects and 

Developmental Disabilities: Improve the 

health and quality of life of Americans 

with disabilities. 

Activities: Activities for Levels II and 

III: Note that items (a) through (e) relate 

to activities for both Level II and III 

State applicants. Items (f) and (g) below 

relate only to Level II State applicants. 

(a) Establish the organizational 

location and focus for the project within 

the applicant agency and engage key 

collaborators (e.g., disability service 

organizations, advocacy groups, 

universities) in the design and 

attainment of program goals and 

objectives. 

(b) Expand or develop an advisory 

function comprised of key partners 

representing the disability community. 

The advisory group will contribute to 

the policy and planning functions of the 

applicant. At least 30 percent of the 

advisory membership must have a 

disabling condition. 

(c) Collect and analyze data using 

survey questions in the Behavioral Risk 

Factor Surveillance System (BRFSS) or 

other survey instruments. 

(d) Investigate and document the 

process (to be or already) established of 

gaining access to or obtaining 

information from administrative data 

within the State to plan and implement 

activities to prevent secondary 

conditions and improve the health of 

people with disabilities to which the 

data relate.

(e) Disseminate health promotion 

information through diverse and 

innovative marketing plans. 

(f) Plan, implement and evaluate over 

the project period health promotion 

interventions related to Chapter 6 

objectives in Healthy People 2010 or the 

leading health indicators for people 

with disabilities. 

(g) Promote and help develop strategic 

planning instruments that will influence 

State-level public health and health 

promotion activities such as Healthy 

People 2010 objectives. 

In a cooperative agreement, CDC staff 

is substantially involved in the program 

activities, above and beyond routine 

grant monitoring. 

CDC Activities for this program are as 

follows: 

• Provide scientific and 

programmatic TA as requested or 

indicated in the planning and conduct 

of disability data collection, 

communications, and health promotion 

activities. 

• Provide a point of referral and 

coordination for State, regional and/or 

national data pertinent to the disabling 

process. 

Federal Register / Vol. 69, No. 212 / Wednesday, November 3, 2004 / Notices 64063

• Provide assistance to States in 

regard to BRFSS, or other survey-based 

sources of data. 

• Facilitate coordination with other 

federal statistical research and data 

resources. 

• Assist State projects in their 

development of program evaluation 

measures and processes. 

II. Award Information 

Type of Award: Cooperative 

Agreement. CDC involvement in this 

program is listed in the Activities 

Section above. 

Fiscal Year Funds: 2005. 

Approximate Total Funding:

$2,500,000. (This amount is an estimate, 

and is subject to availability of funds.) 

Approximate Number of Awards: 9–

11. 

Approximate Average Award:

$280,000 for Level II; $125,000 for Level 

III. (These amounts are for the first 12-

month budget period, and includes both 

direct and indirect costs.) 

Floor of Award Range: $175,000 for 

Level II; $125,000 for Level III. 

Ceiling of Award Range: $360,000 for 

Level II; $150,000 for Level III. 

Anticipated Award Date: April 1, 

2005. 

Budget Period Length: 12 months. 

Project Period Length: Two years. 

Level II: CDC anticipates making up to 

7 awards for projects which will be 

designated as Level II states. Funding 

constraints dictate that no more than 

one of the eligible states will receive an 

award at the $360,000 level. The average 

award for remaining states eligible as a 

Level II applicant will be $280,000. 

Requests for Level II awards in excess of 

$360,000 will be considered as nonresponsive and will be returned to the 

applicant. The major criteria for Level II 

awards will be that intervention 

programs for persons with disabilities 

are established and being implemented 

within the agency jurisdiction and 

constituency served. 

Level III: CDC anticipates making up 

to 4 awards for projects which will be 

designated as Level III states. It is 

expected that Level III awards will 

average $125,000 with no award to be 

made in excess of $150,000. Requests 

for Level III awards in excess of 

$150,000 will be considered as nonresponsive and will be returned to the 

applicant. Funding for Level III projects 

is designed to develop State 

infrastructure, and short-term 

implementation of intervention 

activities is not required.

Throughout the project period, CDC’s 

commitment to continuation of awards 

will be conditioned on the availability 

of funds, evidence of satisfactory 

progress by the recipient (as 

documented in required reports), and 

the determination that continued 

funding is in the best interest of the 

Federal Government. 

III. Eligibility Information 

III.1. Eligible Applicants 

Assistance will be provided to the 

health departments of States or their 

bona fide agents or designees, including 

the District of Columbia, the 

Commonwealth of Puerto Rico, the 

Virgin Islands, the Commonwealth of 

the Northern Mariana Islands, American 

Samoa, Guam, federally recognized 

Indian tribal governments, the 

Federated States of Micronesia, the 

Republic of the Marshall Islands, and 

the Republic of Palau. 

Eligibility is also extended to agencies 

and organizations other than the official 

health department. In those cases, these 

entities must provide written 

concurrence from that health agency 

and describe the proposed collaborative 

relationship. Under that circumstance, 

the role of the official State health 

agency must be shown to be 

complementary, collaborative, and 

demonstrate clearly defined 

programmatic commitments and 

obligations. 

Only one application from each State 

or Territory may be submitted. The 

agency determined to be the applicant 

for the State may apply for more than 

one Level (i.e. Level II or Level III) of 

funding under the eligibility 

requirements for each. Once that agency 

is determined, no other agency within 

that State can submit an application for 

any other Level of funding. However, a 

complete and separate application must 

be submitted from that same applicant 

agency/entity based on the program 

requirements and evaluation criteria for 

that component (Level) of this 

announcement. Only one award will be 

issued per State. 

States are considered the most 

appropriate applicants since the 

national goals of this program include 

developing capacity in all States and 

their delivery systems to monitor, 

characterize, and improve the health of 

people with disabilities and prevent 

secondary conditions. 

Two levels of cooperative agreements 

will be awarded: 

Level II: Eligible applicants for Level 

II funding are States currently funded 

under CDC PA 02007, State 

Implementation Projects for Preventing 

Secondary Conditions and Promoting 

the Health of People with Disabilities. 

Eligible states include Arkansas, 

California, Illinois, Massachusetts, 

Montana, New Jersey, Oregon, Rhode 

Island, Vermont, and Virginia. In 

addition, eligible applicants include the 

District of Columbia, all States, federally 

recognized Indian Tribes and United 

States Territories. 

To be eligible, applicants for Level II 

must also provide: 

(a) The State Plan for Disability and 

Health. The Plan can be in final form or 

in the process of final review. 

(b) An established and functioning 

disability and health advisory 

component of which at least 30 percent 

of the members are people with 

disabilities. The advisory group 

contributes to the policy and planning 

functions of the applicant. A listing of 

the advisory committee membership 

with their areas of expertise and interest 

is to be provided and certified by the 

committee/council chairperson, with an 

indication only as to the number of 

persons with disabilities within that 

group. 

A copy of the State Plan and the 

composition and function statement of 

the Advisory Council must be provided 

as attachments to the application. 

Level III: Eligible applicants for Level 

III funding are the District of Columbia, 

all States, federally recognized Indian 

Tribes and United States Territories 

regardless of their current CDC 

Disability and Health Program funding 

status. 

CDC will conduct a conference call 

November 16, 2004 with prospective 

applicants to answer questions 

regarding this announcement. If you 

wish to participate, contact by e-mail 

the official noted for Program TA in the 

‘‘Agency Contacts’’ section of this 

announcement (dbetts@cdc.gov). You 

will be informed by return e-mail as to 

the time, telephone number, and 

passcode for that call. You are 

encouraged to provide advance 

questions that will be part of the general 

discussion during the call. 

III.2. Cost Sharing or Matching

Matching funds are not required for 

this program. 

III.3. Other 

If you request a funding amount 

greater than the ceiling of the award 

range, your application will be 

considered non-responsive, and will not 

be entered into the review process. You 

will be notified that your application 

did not meet the submission 

requirements. 

Special Requirements:

If your application is incomplete or 

non-responsive to the special 

requirements listed in this section, it 

will not be entered into the review 

64064 Federal Register / Vol. 69, No. 212 / Wednesday, November 3, 2004 / Notices 

process. You will be notified that your 

application did not meet submission 

requirements. 

• Late applications will be considered 

non-responsive. See section ‘‘IV.3. 

Submission Dates and Times’’ for more 

information on deadlines. 

• Note: Title 2 of the United States 

Code Section 1611 states that an 

organization described in Section 

501(c)(3) of the Internal Revenue Code 

that engages in lobbying activities is not 

eligible to receive Federal funds 

constituting an award, grant, or loan. 

IV. Application and Submission 

Information 

IV.1. Address To Request Application 

Package 

To apply for this funding opportunity 

use application form PHS 5161. 

Application forms and instructions are 

available on the CDC Web site, at the 

following Internet address: http://

www.cdc.gov/od/pgo/forminfo.htm.

If you do not have access to the 

Internet, or if you have difficulty 

accessing the forms on-line, you may 

contact the CDC Procurement and 

Grants Office Technical Information 

Management Section (PGO–TIMS) staff 

at: 770–488–2700. Application forms 

can be mailed to you. 

IV.2. Content and Form of Submission 

Letter of Intent (LOI): A non-binding 

letter of intent is requested from 

prospective applicants. The letter 

should not exceed one page. It should 

identify the announcement number, the 

proposed project director, and denote 

whether funding Level II or III is being 

proposed. This letter will allow CDC to 

determine the amount of interest in the 

announcement, to plan the review more 

efficiently, and to ensure that each 

applicant receives timely and relevant 

information prior to the application 

submission date. Your LOI must be 

written in the following format:

• Maximum number of pages: One 

• Font size: 12-point unreduced 

• Single spaced 

• Paper size: 8.5 by 11 inches 

• Page margin size: One inch 

• Printed only on one side of page 

• Written in plain language, avoid 

jargon

Application: You must submit a 

project narrative with your application 

forms. The narrative must be submitted 

in the following format:

• Maximum number of pages: 35 pages 

if applying for Level II; 25 pages if 

applying for Level III. If your narrative 

exceeds the page limit, only the first 

pages which are within the page limit 

will be reviewed. 

• Font size: 12–14 point unreduced 

• Double spaced 

• Paper size: 8.5 by 11 inches 

• Page margin size: One inch 

• Printed only on one side of page 

• Held together only by rubber bands or 

metal clips; not bound in any other 

way

• Attachments to the application should 

be held to a minimum in keeping to 

those items referenced or required by 

this Announcement. The attachments 

do not count toward the page 

application limit for that funding 

level

Your narrative should address 

activities to be conducted over the 

entire project period. Level II and Level 

III applicants must include the 

following items in the order listed: 

1. Background and Need:

a. Describe the current status of 

disability and health programs in the 

state, and describe your understanding 

of the need for this program in the state. 

Identify the extent of the problem, 

available services and support 

resources, at-risk groups, knowledge 

gaps, and the use of this award in 

meeting such needs. Provide the data 

sources that document the need for the 

program. 

b. Provide justification for 

emphasizing select populations or the 

sub-group of disabling conditions to be 

targeted by the applicant. Provide 

references for any studies or sources 

from which this information was 

obtained. 

2. Collaborations:

a. Discuss the collaborations proposed 

with principal partners in the conduct 

of the project, such as a formal 

university or state agency alliance that 

will have an impact on the capacity of 

the State to mount or improve efforts in 

health promotion and the prevention of 

secondary conditions. Provide letters of 

support describing the nature of each 

collaboration, and the extent of the 

collaborative commitment in the scope 

of work and human and financial 

resources. 

b. Describe progress in developing or 

implementing a formal State Plan for the 

prevention of secondary conditions and 

promoting the health of people with 

disabilities, and describe the role of a 

new or existing advisory function to aid 

in that effort and in other assigned 

responsibilities. 

3. Epidemiologic Capacity:

a. Furnish descriptions of the 

epidemiologic capacity structure in 

place or proposed to coordinate and 

promote data collection and analysis 

including the BRFSS, other state data 

sources, selected administrative data 

sets, and those in conjunction with 

identified partners. 

b. Describe how the university or state 

agency partnership or collaboration 

with the state BRFSS Coordinator or 

other agencies has or will be engaged to 

facilitate epidemiologic excellence. 

Provide data from the BRFSS, other 

state sources, or selected administrative 

data describing both the magnitude of 

disability, and the risk and protective 

factors related to the onset and progress 

of secondary conditions. 

c. Describe how data will, or is being 

used, for policy development and 

planning. 

4. Program Work Plan:

a. Provide measurable and timephased goals and objectives for the 

project period. Objectives should be 

outcome oriented as much as possible, 

rather than focusing on processes or 

outputs. Provide baselines for each 

objective. The work plan should include 

the goal of defining the burden of 

disabilities. 

b. Describe proposed activities that 

will lead to the achievement of the 

stated goals and objectives. Activities 

may include the following:

• Conducting the BRFSS survey and 

analyzing the data 

• Initiating or expanding strategic 

partnerships with specific activities 

identified 

• Providing TA to communities 

• Promoting education and health 

promotion programs for persons with 

disabilities 

• Conducting training of health 

professionals 

• Facilitating access to services for 

persons with disabilities

5. Evaluation Plan: Discuss how the 

project will measure the outcomes of 

proposed targeted activities (e.g., 

increases in public awareness, 

knowledge, behavior, and the overall 

benefits of State Planning and advisory 

activities). Include a description of the 

evaluation design, methods, partners, 

and processes to be followed for 

conducting program evaluation. 

6. Management/Staffing Plan:

a. Provide a description of the 

proposed staffing for the project, and the 

plan to expedite filling of all positions. 

The plan must include the appointment 

of a full time program manager/

coordinator. 

b. Discuss the responsibilities of 

individual staff members including the 

level of effort and time allocation for 

each project objective by staff position. 

c. Describe plans for on-going 

management and operation of the 

project in the event of unexpected 

vacancies, hiring restrictions, or 

difficulty in recruiting for key positions. 

Federal Register / Vol. 69, No. 212 / Wednesday, November 3, 2004 / Notices 64065

d. Describe how the integration of 

disability and health functions as an 

integral component of applicant/health 

agency services and operations will be 

achieved. 

e. Present a graphic flowchart (i.e., 

Gantt chart) denoting time interval 

performance expectations over the first 

budget year. 

7. Budget and Narrative Justification:

Provide a detailed line-item budget and 

narrative justification for all operating 

expenses consistent with and clearly 

related to the proposed objectives and 

planned activities. 

Additional information may be 

included in the application appendices. 

The appendices will not be counted 

toward the narrative page limit. This 

additional information includes:

• Curriculum Vitaes 

• Resumes 

• Organizational Charts 

• Letters of Support 

• Graphic workplans 

• State plans for disability and health 

(Level II only) 

• Listing of Advisory Committee 

membership (Level II only)

You are required to have a Dun and 

Bradstreet Data Universal Numbering 

System (DUNS) number to apply for a 

grant or cooperative agreement from the 

Federal government. The DUNS number 

is a nine-digit identification number, 

which uniquely identifies business 

entities. Obtaining a DUNS number is 

easy and there is no charge. To obtain 

a DUNS number, access http://

www.dunandbradstreet.com or call 1–

866–705–5711. 

For more information, see the CDC 

Web site at: http://www.cdc.gov/od/pgo/

funding/pubcommt.htm. If your 

application form does not have a DUNS 

number field, please write your DUNS 

number at the top of the first page of 

your application, and/or include your 

DUNS number in your application cover 

letter.

Additional requirements that may 

require you to submit additional 

documentation with your application 

are listed in section ‘‘VI.2. 

Administrative and National Policy 

Requirements.’’

IV.3. Submission Dates and Times 

LOI Deadline Date: December 3, 2004. 

CDC requests that you send an LOI if 

you intend to apply for this program. 

Although the LOI is not required, not 

binding, and does not enter into the 

review of your subsequent application, 

the LOI will be used to gauge the level 

of interest in this program, and to allow 

CDC to plan the application review. 

Application Deadline Date: January 3, 

2005. 

Explanation of Deadlines:

Applications must be received in the 

CDC Procurement and Grants Office by 

4 p.m. Eastern Time on the deadline 

date. If you submit your application by 

the United States Postal Service or 

commercial delivery service, you must 

ensure that the carrier will be able to 

guarantee delivery by the closing date 

and time. If CDC receives your 

submission after closing due to: (1) 

Carrier error, when the carrier accepted 

the package with a guarantee for 

delivery by the closing date and time, or 

(2) significant weather delays or natural 

disasters, you will be given the 

opportunity to submit documentation of 

the carriers guarantee. If the 

documentation verifies a carrier 

problem, CDC will consider the 

submission as having been received by 

the deadline. 

This announcement is the definitive 

guide on LOI and application content, 

submission address, and deadline. It 

supersedes information provided in the 

application instructions. If your 

submission does not meet the deadline 

above, it will not be eligible for review, 

and will be discarded. You will be 

notified that you did not meet the 

submission requirements. 

CDC will not notify you upon receipt 

of your submission. If you have a 

question about the receipt of your LOI 

or application, first contact your courier. 

If you still have a question, contact the 

PGO–TIMS staff at: 770–488–2700. 

Before calling, please wait two to three 

days after the submission deadline. This 

will allow time for submissions to be 

processed and logged. 

IV.4. Intergovernmental Review of 

Applications 

Your application is subject to 

Intergovernmental Review of Federal 

Programs, as governed by Executive 

Order (EO) 12372. This order sets up a 

system for state and local governmental 

review of proposed federal assistance 

applications. You should contact your 

state single point of contact (SPOC) as 

early as possible to alert the SPOC to 

prospective applications, and to receive 

instructions on your state’s process. 

Click on the following link to get the 

current SPOC list: http://

www.whitehouse.gov/omb/grants/

spoc.html.

IV.5. Funding Restrictions 

Restrictions, which must be taken into 

account while writing your budget, are 

as follows: 

• Reimbursement of pre-award costs 

is not allowed. 

• Funds may not be used for 

construction. 

• Funds may not be used to supplant 

State, local, or other applicant funds for 

the purpose of this cooperative 

agreement. 

• Funds may not be used to lease or 

purchase space or facilities.

• Funds may not be used for patient 

care. 

If you are requesting indirect costs in 

your budget, you must include a copy 

of your indirect cost rate agreement. If 

your indirect cost rate is a provisional 

rate, the agreement should be less than 

12 months of age. 

Guidance for completing your budget 

can be found on the CDC Web site, at 

the following Internet address: http://

www.cdc.gov/od/pgo/funding/

budgetguide.htm.

IV.6. Other Submission Requirements 

LOI Submission Address: Submit your 

LOI by express mail, delivery service, 

fax, or e-mail to: Donald Betts, CDC, 

NCBDDD, 1600 Clifton Road, MS E 88, 

Atlanta, GA 30333, 404–498–3957, 404–

498–3060, dbetts@cdc.gov.

Application Submission Address:

Submit the original and two hard copies 

of your application by mail or express 

delivery service to: Technical 

Information Management Section, CDC 

Procurement and Grants Office, 2920 

Brandywine Road, Atlanta, GA 30341. 

Applications may not be submitted 

electronically at this time. 

V. Application Review Information 

V.1. Criteria 

Level II and Level III applicants will 

be evaluated individually against the 

following criteria by an independent 

review group appointed by CDC: 

1. Program Work Plan: (20 Points) 

a. The extent to which the formal 

work plan includes a clear and concise 

presentation of project goals and 

objectives which are specific, 

measurable, achievable, and timereferenced. 

b. The extent to which the applicant 

effectively documents its plan to 

provide TA, education and training, and 

health promotion programs. 

c. The degree to which the applicant 

has met the CDC Policy requirements 

regarding the inclusion of women, 

ethnic, and racial groups in proposed 

research. This includes: 

(1) The proposed justification when 

representation is limited or absent; 

(2) A statement as to whether the 

design of the study is adequate to 

measure differences when warranted; 

and 

(3) A statement as to whether the 

plans for recruitment and outreach for 

64066 Federal Register / Vol. 69, No. 212 / Wednesday, November 3, 2004 / Notices 

study participants include the process 

of establishing partnerships with 

community(ies) and recognition of 

mutual benefits. 

2. Evidence of Collaboration: (20 Points) 

a. The extent to which the proposed 

collaborations are well documented 

with letters of commitment conveying 

specific indications as to the level of 

involvement and material effort to be 

provided in support of project 

objectives. 

b. The extent to which the applicant 

adequately describes the proposed or 

existing advisory function, including 

evidence of representation of persons 

with disabilities and their role and 

capacity to influence State-level policy. 

c. The extent to which the applicant 

presents evidence of strong partnerships 

between the state health department, 

universities, and community-based 

organizations, and describes how these 

collaborations will result in successful 

infrastructure development. 

d. The extent to which the proposed 

approach demonstrates an effective 

process to develop and publish a State 

strategic plan with a Healthy People 

2010 emphasis, and/or policy directive 

for the prevention of secondary 

conditions as a precursor to the 

development of the State Plan. 

3. Epidemiologic Capacity: (20 Points) 

a. The extent to which the application 

conveys the epidemiologic capacity and 

structure in place to coordinate and 

facilitate disability-related data 

collection, analysis, interpretation, and 

dissemination. 

b. The extent to which the applicant 

adequately describes how it will 

conduct the BRFSS, access other State 

disability information sources related to 

the population of interest such as 

administrative data sets; and how such 

data is currently, or will be utilized. 

4. Program Evaluation: (20 Points)

a. The extent to which the applicant 

presents an appropriate and viable plan 

for the overall evaluation of the project; 

including the design, methods 

(quantitative methods as well as 

qualitative approaches such as focus 

groups), partners, and processes to be 

followed for conducting project 

evaluation. 

b. The extent to which the applicant 

adequately outlines the methods and 

process by which it will self-evaluate its 

performance towards meeting all 

specified time-phased objectives. 

5. Evidence of Need and Understanding 

of the Problem: (10 Points) 

a. The extent to which the applicant 

provides an adequate description and 

understanding of the magnitude of 

disabilities showing evidence (as 

available) of estimates of prevalence, 

demographic indicators, severity, effect 

on families and caregivers, and 

associated costs. 

b. The degree to which the applicant 

provides a suitable description of the 

extent of current activities related to 

disability and health, including those 

addressing the prevention of secondary 

conditions within the State. 

6. Management/Staffing Plan: (10 

Points) 

a. The extent to which the applicant 

provides adequate descriptions of key 

staff responsibilities addressing 

proposed major activities. 

b. The extent to which the 

organizational placement of the project 

assures optimal visibility and influence 

based on evidence provided by 

applicant agency leadership. 

c. The extent to which the applicant 

addresses how it will assure and 

achieve integration of disability and 

health functions as an integral 

component of applicant/health agency 

services and operations. 

7. Budget Justification: (Not Scored) 

The extent to which the proposed 

budget is reasonable, related to the 

proposed objectives and activities. 

8. Human Subjects if Applicable: (Not 

Scored) 

The extent to which the applicant 

complies with the Department of Health 

and Human Services Regulations (45 

CFR Part 46) regarding the protection of 

human subjects. 

V.2. Review and Selection Process 

Applications will be reviewed for 

completeness by the Procurement and 

Grants Office (PGO) staff, and for 

responsiveness by the National Center 

on Birth Defects and Developmental 

Disabilities (NCBDDD). Incomplete 

applications and applications that are 

non-responsive to the eligibility criteria 

will not advance through the review 

process. Applicants will be notified that 

their application did not meet 

submission requirements. 

An objective review panel appointed 

by CDC will evaluate complete and 

responsive applications according to the 

criteria listed in the ‘‘V.1. Criteria’’

section above. Members of the objective 

review panel will be appointed in 

accordance with Department of Health 

and Human Services policy. 

Applications will be funded in order 

by score and rank determined by the 

review panel. In addition, the following 

factors may affect the funding decission: 

maintaining geographic diversity, and 

preference to applicants funded in a 

previous project period. 

CDC will provide justification for any 

decision to fund out of rank order. 

V.3. Anticipated Announcement and 

Award Dates 

It is anticipated that awards will be 

announced on March 15, 2005. 

VI. Award Administration Information 

VI.1. Award Notices 

Successful applicants will receive a 

Notice of Grant Award (NGA) from the 

CDC Procurement and Grants Office. 

The NGA shall be the only binding, 

authorizing document between the 

recipient and CDC. The NGA will be 

signed by an authorized Grants 

Management Officer, and mailed to the 

recipient fiscal officer identified in the 

application. 

Unsuccessful applicants will receive 

notification of the results of the 

application review by mail. 

VI.2. Administrative and National 

Policy Requirements 

45 CFR Parts 74 and 92

For more information on the Code of 

Federal Regulations, see the National 

Archives and Records Administration at 

the following Internet address: http://

www.access.gpo.gov/nara/cfr/cfr-tablesearch.html.

The following additional 

requirements apply to this project:

• AR–1 Human Subjects 

Requirements. 

• AR–2 Requirement for Inclusion of 

Women and Racial Minorities in 

Research. 

• AR–7 Executive Order 12372. 

• AR–9 Paperwork Reduction Act 

Requirements. 

• AR–10 Smoke-Free Workplace 

Requirements. 

• AR–11 Healthy People 2010. 

• AR–12 Lobbying Restrictions. 

• AR–22 Research Integrity.

Additional information on these 

requirements can be found on the CDC 

Web site at the following Internet 

address: http://www.cdc.gov/od/pgo/

funding/ARs.htm.

VI.3. Reporting Requirements 

You must provide CDC with an 

original, plus two hard copies of the 

following reports: 

1. Interim progress report, due no less 

than 90 days before the end of the 

budget period. The progress report will 

Federal Register / Vol. 69, No. 212 / Wednesday, November 3, 2004 / Notices 64067

serve as your non-competing 

continuation application, and must 

contain the following elements: 

a. Current Budget Period Activities 

Objectives. 

b. Current Budget Period Financial 

Progress. 

c. New Budget Period Program 

Proposed Activity Objectives. 

d. Budget. 

e. Measures of Effectiveness. 

f. Additional Requested Information. 

2. Financial status report no more 

than 90 days after the end of the budget 

period. 

3. Final financial and performance 

reports, no more than 90 days after the 

end of the project period. 

These reports must be mailed to the 

Grants Management or Contract 

Specialist listed in the ‘‘Agency 

Contacts’’ section of this announcement. 

VII. Agency Contacts 

We encourage inquiries concerning 

this announcement. 

For general questions, contact: 

Technical Information Management 

Section, CDC Procurement and Grants 

Office, 2920 Brandywine Road, Atlanta, 

GA 30341, Telephone: 770–488–2700. 

For program TA, contact: Donald 

Betts, Lead Public Health Analyst, CDC, 

NCBDDD, 1600 Clifton Road, NE (MS E 

88), Telephone: 404–498–3957, E-mail: 

dbetts@cdc.gov.

For financial, grants management, or 

budget assistance, contact:

Gary Teague, Grants Management 

Specialist, CDC Procurement and Grants 

Office, 2920 Brandywine Road, Atlanta, 

GA 30341, Telephone: 770–488–1981, 

E-mail: GTeague@cdc.gov.

VIII. Other Information 

This and other CDC funding 

opportunity announcements can be 

found on the CDC Web site, Internet 

address: http://www.cdc.gov. Click on 

‘‘Funding’’ then ‘‘Grants and 

Cooperative Agreements.’’

Dated: October 28, 2004. 

William P. Nichols, 

Acting Director, Procurement and Grants 

Office, Centers for Disease Control and 

Prevention.

[FR Doc. 04–24514 Filed 11–2–04; 8:45 am] 

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee for Injury 

Prevention and Control 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following subcommittee 

and committee meetings.

Name: Science and Program Review 

Subcommittee (SPRS). 

Time and Date: 8 a.m.–12 p.m., November 

17, 2004. 

Place: Hyatt Regency Atlanta, 265 

Peachtree Street, Atlanta, Georgia 30303–

1294. 

Status: Open to the public, limited only by 

the space available. 

Purpose: The SPRS provides advice on the 

needs, structure, progress and performance of 

programs of the National Center for Injury 

Prevention and Control (NCIPC), as well as 

second-level scientific and programmatic 

review for applications for research grants, 

cooperative agreements, and training grants 

related to injury control and violence 

prevention, and recommends approval of 

projects that merit further consideration for 

funding support. The SPRS also advises on 

priorities for research to be supported by 

contracts, grants, and cooperative agreements 

and provides concept review of program 

proposals and announcements. 

Matters to be Discussed: The SPRS will 

discuss the acute care research agenda and 

details of the 2005 secondary review meeting 

to be held in Atlanta.

Name: Subcommittee on Intimate Partner 

Violence and Sexual Assault (SIPVSA). 

Time and Date: 8:45 a.m.–11:30 a.m., 

November 17, 2004. 

Place: Hyatt Regency Atlanta, 265 

Peachtree Street, Atlanta, Georgia 30303–

1294. 

Status: Open to the public, limited only by 

the space available. 

Purpose: To advise and make 

recommendations to the full advisory 

committee and the Director, NCIPC, 

regarding feasible goals for prevention and 

control of domestic and sexual violence. The 

SIPVSA makes recommendations regarding 

strategies, objectives, and priorities in 

programs, policies and research, and 

continually evaluates NCIPC’s research 

agenda priorities and implementation related 

to intimate partner violence and sexual 

assault. 

Matters to be Discussed: The SIPVSA will 

hold a conference call meeting to discuss and 

review a draft white paper on intimate 

partner and sexual violence prevention. 

Place: Hyatt Regency Atlanta, 265 

Peachtree Street, Atlanta, Georgia 30303–

1294. 

Status: Open to the public, limited only by 

the space available.

Name: Advisory Committee for Injury 

Prevention and Control. 

Time and Dates: 1 p.m.–5 p.m., November 

17, 2004, 8:30 a.m.–2:30 p.m., November 18, 

2004. 

Place: Hyatt Regency Atlanta, 265 

Peachtree Street, Atlanta, Georgia 30303–

1294. 

Status: Open to the public, limited only by 

the space available.

Purpose: The Committee advises and 

makes recommendations to the Secretary, 

Health and Human Services, the Director, 

CDC, and the Director, NCIPC, regarding 

feasible goals for the prevention and control 

of injury. The Committee makes 

recommendations regarding policies, 

strategies, objectives, and priorities, and 

reviews progress toward injury prevention 

and control. 

Matters to be Discussed: Prior to the full 

committee meeting, there will be a brief 

meeting conducted by conference call of the 

Working Group on Injury Control and 

Infrastructure Enhancement, a group formed 

to report to the full committee identifying 

gaps and suggesting ways to enhance injury 

prevention efforts. The Working Group will 

discuss drafting a white paper focusing on 

defining injury infrastructure and developing 

a simple mechanism to assess current efforts 

underway throughout the injury field to 

enhance that infrastructure. Starting at 1 

p.m., the full committee will meet. Agenda 

items include reports from the 

Subcommittees and Working Group; an 

update by the Acting Director, NCIPC, on 

CDC/Agency for Toxic Substances and 

Disease Registry (ATSDR) Futures Initiative; 

goals management at CDC/ATSDR process to 

date, by life stages, for preparedness and 

response and goals management for injury 

prevention and control; core competencies 

for injury and violence prevention; 

surveillance for fatal and non-fatal injuries; 

health economics research at NCIPC; and an 

update on NCIPC preparedness and response 

activities. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: Ms. 

Louise Galaska, Executive Secretary, ACIPC, 

NCIPC, CDC, 4770 Buford Highway, NE, M/

S K02, Atlanta, Georgia 30341–3724, 

telephone (770) 488–4694. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and ATSDR.

Dated: October 24, 2004. 

B. Kathy Skipper, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention.

[FR Doc. 04–24515 Filed 11–2–04; 8:45 am] 

BILLING CODE 4163–18–P